arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Trulieve Cannabis Corp.

TRLV
$10.88 ▼ -0.70 (-6.04%) at close
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
27 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
47
Health
Weak
Bearish
auto_awesome

Analytical Summary

Trulieve Cannabis Corp. faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.1B
Dividend Yield —
Revenue Growth -10.3% ↘
Op. Margin -136.7% ↘
ROIC -200.1% ↘
FCF / Share $0.28 ↘
Trailing P/E —
Price / Book —
FCF Yield 2.5%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$270.95M
↓ -10.3% —
Net Income Profit after all expenses
$-406.06M
↓ -2420.4% —
Operating Margin Operating profit as % of sales
-136.7%
↓ -1197.6% 61th
FCF / Share Free cash flow per share
$0.28
↓ -4.7% —
Long-Term Debt Long-term obligations
$195.82M
— +0.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
53
Financial Health ↓
60
Cash Quality ↑
7

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 27 quarters